Position in UTHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$981,795
+$1,600 QoQ
Shares Held
1,812
+9.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#468
of 870 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $12,595,878 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
49,202 | $5,458,469 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,812 | $981,795 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
215,316 | $895,714 | |
| 4 | HROW |
Harrow, Inc.
|
16,489 | $700,287 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,469 | $693,489 | |
| 6 | VTRS |
Viatris Inc
|
40,486 | $642,917 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,628 | $559,156 | |
| 8 | ZTS |
Zoetis Inc.
|
7,722 | $554,901 |
All Filings in UTHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $981,795 | 1,812 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $980,195 | 1,653 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $313,788 | 644 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $241,045 | 575 | Shares | Sole | 2025-11-14 | |
| 2021-09-30 | $286,837 | 1,554 | Shares | Sole | 2022-02-15 | |
| 2020-06-30 | $256,036 | 2,116 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $205,686 | 2,169 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||